These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Abbott KC, Agodoa LY. Clin Nephrol; 2001 Sep; 56(3):207-10. PubMed ID: 11597035 [Abstract] [Full Text] [Related]
5. Characteristics and survival of young adults who started renal replacement therapy during childhood. Kramer A, Stel VS, Tizard J, Verrina E, Rönnholm K, Pálsson R, Maxwell H, Jager KJ. Nephrol Dial Transplant; 2009 Mar; 24(3):926-33. PubMed ID: 18840894 [Abstract] [Full Text] [Related]
6. Renal replacement therapy in the Canary Islands: demographic and survival analysis. Lorenzo V, Sanchez E, Vega N, Hernandez D. J Nephrol; 2006 Mar; 19(1):97-103. PubMed ID: 16523433 [Abstract] [Full Text] [Related]
7. Long-term outcome of autologous stem cell transplantation in light chain deposition disease. Lorenz EC, Gertz MA, Fervenza FC, Dispenzieri A, Lacy MQ, Hayman SR, Gastineau DA, Leung N. Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602 [Abstract] [Full Text] [Related]
8. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis. Decourt A, Gondouin B, Delaroziere JC, Brunet P, Sallée M, Burtey S, Dussol B, Ivanov V, Costello R, Couchoud C, Jourde-Chiche N. Clin J Am Soc Nephrol; 2016 Mar 07; 11(3):431-41. PubMed ID: 26728585 [Abstract] [Full Text] [Related]
15. End-stage renal disease and its treatment in Latin America in the twenty-first century. Cusumano A, Garcia-Garcia G, Di Gioia C, Hermida O, Lavorato C, Carreño CA, Torrico MP, Batista PB, Romão JE, Badal HP, Miranda SE, Gomez R, Calderon MC, Sanchez SH, Lopez MA, Moscoso J, Merino RL, Polo JV, Lopez A, Romero NJ, Garcia R, Acosta BV, Lopez AS, Delpin ES, Mena E, González C, Milanés CL, Acchiardo S. Ren Fail; 2006 Jun 07; 28(8):631-7. PubMed ID: 17162420 [Abstract] [Full Text] [Related]
17. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Goovaerts T, Jadoul M, Goffin E. Nephrol Dial Transplant; 2005 Sep 07; 20(9):1842-7. PubMed ID: 15919693 [Abstract] [Full Text] [Related]
18. The ERA-EDTA cohort study--comparison of methods to predict survival on renal replacement therapy. Geddes CC, van Dijk PC, McArthur S, Metcalfe W, Jager KJ, Zwinderman AH, Mooney M, Fox JG, Simpson K. Nephrol Dial Transplant; 2006 Apr 07; 21(4):945-56. PubMed ID: 16339161 [Abstract] [Full Text] [Related]
19. Dialysis in Israel, 1989-2005--time trends and international comparisons. Calderon-Margalit R, Gordon ES, Hoshen M, Kark JD, Rotem A, Haklai Z. Nephrol Dial Transplant; 2008 Feb 07; 23(2):659-64. PubMed ID: 17881428 [Abstract] [Full Text] [Related]
20. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry. Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ. Am J Kidney Dis; 2015 Oct 07; 66(4):613-20. PubMed ID: 25975963 [Abstract] [Full Text] [Related] Page: [Next] [New Search]